Agilent announces global distribution agreement with Proscia to accelerate data-driven precision medicine
Agilent Technologies Inc. announced a multi-year distribution agreement with Proscia to offer a comprehensive digital diagnostic pathology system. Combining Agilent's pathology staining solutions with Proscia’s Concentriq Dx enterprise pathology platform will empower pathology labs to transform diagnostic efficiency and quality to improve patient health outcomes.
Proscia's Concentriq Dx scalable enterprise pathology platform powers primary diagnostic workflows from individual labs to even the largest laboratory networks. It offers a pathologist-centric user experience across a robust digital environment for viewing, managing, and analyzing images, helping to drive efficiency. An open platform, Concentriq Dx can integrate with leading hardware and software solutions, including scanners and image analysis applications, and is designed to realize the promise of AI, centralizing a laboratory’s existing technology ecosystem, and meeting its future needs.
